Breaking: UPC hits NanoString with European sales ban

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Breaking: UPC hits NanoString with European sales ban

Munich.jpg

The decision marks the first time the Unified Patent Court has issued a preliminary injunction after an oral hearing involving both sides in a dispute

The Unified Patent Court granted US biotech company 10x Genomics a preliminary injunction against rival NanoString today, September 19, in a major first for the new court.

Presiding Judge Matthias Zigann, who handed down the order, said the UPC would decide on another PI request on October 10.

It was initially expected that there would be a decision on both applications today.

NanoString can challenge today’s decision at the UPC Court of Appeal in Luxembourg.

The order marks the first time the UPC has issued a PI after hearing oral arguments between both parties in a dispute since the court started hearing cases in June.

The UPC previously issued an ex parte injunction in a dispute between Swiss bike manufacturers myStromer and Revolt Zycling.

Today’s order comes after a hearing at the Munich local division on September 6. Sources who attended that hearing had told Managing IP that an injunction was likely.

One of 10x’s lawyers, Bardehle Pagenberg partner Tilman Müller-Stoy, described the judges as among the best-prepared he had seen in his career after the hearing.

Zigann heard the case alongside three other judges – Tobias Pichlmaier, András Kupecz, and Eric Enderlin.

The PI is the second injunction 10x has obtained from a court in Germany against NanoString so far this year.

The Munich Regional Court issued an anti-anti-suit injunction against NanoString in April, believed to be the first order of its kind in a German life sciences suit.

The order forced NanoString to withdraw an anti-suit injunction it had filed at the US District Court for the District of Delaware.

more from across site and SHARED ros bottom lb

More from across our site

Yossi Sivan explains how Israeli judgment is a pro-brand owner departure from the norm and why it sends a strong message that corporate structures are not always a shield
Halim Shehadeh, group CEO of IP firm CWB, says that in the rush to discuss what AI can do, IP firms are overlooking the more important question of whether they are ready
Caitlin Heard, who formally joined the firm from CMS last month, says she is excited by the ‘energy’ of the London office
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
The initial contempt of court claim targeted Stobbs and the firm’s client for allegedly interfering with the administration of justice
Acquisition of platform developed by Boehmert & Boehmert lawyer set to create a combined platform for patent drafting and prosecution in Europe
Partner Rob Jacob unveils plans to offer a beginning-to-end trademark service, how to make prosecution profitable, and why IP ‘buy-in’ from the CEO stands the firm in good stead
Attorneys at Di Blasi, Parente & Associados share how the protection of trade secrets strengthens innovation by bringing together legal practice, regulatory developments, and established international references
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
Gift this article